Slf2 And Smc5 Dysfunction Drives HSC Aging And Predisposes To MDS, Defining A New Inherited Bone Marrow Failure Syndrome
Scientists have uncovered a new genetic basis for a serious blood disorder, revealing that problems with two specific genes, SLF2 and SMC5, can lead to a condition where the bone marrow struggles to produce healthy blood cells. This discovery expands our understanding of inherited bone marrow failure syndromes, a group of disorders where genetic abnormalities impair the bone marrow’s ability to function properly.
The research shows that when these genes are not working correctly, it causes the stem cells responsible for making all types of blood cells to age prematurely. This “cellular aging” process, along with damage to the cell’s genetic material (genomic instability) and activation of stress response pathways (like p53/p21), impairs the stem cells’ ability to produce a balanced supply of blood cells. As a result, individuals with these genetic defects are not only prone to bone marrow failure but also face a higher risk of developing myelodysplastic syndromes (MDS), a type of blood cancer, often at a young age.
This finding is particularly important for patients diagnosed with Atelis Syndrome, a neurodevelopmental disorder previously linked to SLF2 and SMC5 variants. The study clarifies that Atelis Syndrome is also an inherited bone marrow failure syndrome, meaning patients require careful monitoring for blood-related complications. Encouragingly, correcting these genetic errors in patient-derived cells was shown to reverse the cellular abnormalities, offering hope for future therapeutic strategies and improved diagnosis for unexplained cases of bone marrow failure and MDS.
Source: link to paper